Traditional MedicareCoverageMedium impact
MolDX: Molecular Testing for Solid Organ Allograft Rejection
Medicare/CMS - LCD·Transplant Surgery, Nephrology, Cardiology +1 more·Local Coverage Determination
Effective date
Jun 18, 2026
We identified it
Jun 23, 2026
Summary
This is a new Local Coverage Determination for molecular testing used to detect solid organ transplant rejection. The policy establishes Medicare coverage criteria and billing guidelines for specialized genetic tests that monitor transplanted organs like kidneys, hearts, and livers.
Action Required
Before June 18, 2026: Billing team must review the full LCD policy text to identify specific CPT codes, coverage criteria, and documentation requirements for molecular transplant rejection testing. Update billing system with any prior authorization requirements and medical necessity criteria. Coordinate with transplant providers to ensure proper documentation is captured.